Two South Boston beaches earned perfect scores in a new water quality report for marine beaches, but others are still registered concerning bacteria levels.

Cops, criminals, class conflict, Afflecks, and accents—why does Boston have its own movie subgenre? If you can't access your feeds, please contact customer support. Thanks! Check your phone for ...

Boston Scientific just scored a clean bill of health from analysts, with Leerink Partners launching coverage and slapping on an “outperform” rating along with a target price of $118. Twenty-two ...

Boston Scientific’s Operating Cash Flow (OCF) for the same period was $3.8 billion, indicating a good OCF margin of 21.7% compared to the S&P 500’s 14.9%.

Boston Scientific Corporation has a price-to-sales ratio of 9.01. Their price-to-book-value ratio is 7.15. The EV/EBITDA is currently at 34.0. The price/free cash flow for Boston Scientific ...

Boston Scientific BSX underwent analysis by 13 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their ...

Review the current valuation for Boston Scientific Corp (BSX:XNYS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.

Boston Scientific appears to be flexing a premium price tag that’s a bit too buff for its own balance sheet. Analysts using a two-stage Discounted Cash Flow (DCF) model calculated an intrinsic value ...

Boston Consulting Group CEO apologizes for Israeli-backed Gaza aid project Top consulting firm fires two partners over involvement in aid initiative beset by violence and controversy. June 6, 2025 ...

Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Here is how Boston Scientific (BSX) and Dare Bioscience, Inc. (DARE) have performed compared to their sector so far this year.